-+ 0.00%
-+ 0.00%
-+ 0.00%

SIRONAX ADVANCES ENROLLMENT IN PHASE 2 FORGE-LM OBESITY TRIAL OF NAMPT ACTIVATOR SIR4156

Reuters·10/13/2026 11:02:30

Please log in to view news